This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetic Foot Ulcers
and you are
over 18
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of the current study is to support the performance and safety of Woulgan® in the treatment of diabetic foot ulcer in comparison with the commercially available hydrogel Intrasite. Healing and untoward medical events to be evaluated.

Provided treatments

  • Device: Woulgan Gel
  • Device: Intrasite Hydrogel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02631512. The sponsor of the trial is Biotec Pharmacon ASA and it is looking for 62 volunteers for the current phase.
Official trial title:
Evaluation of Woulgan in Diabetic Foot Ulcer Compared With a Commercial Hydrogel